This study assess the effectiveness of systematic preconception genetic risk assessment to improve reproductive outcomes in women and their partners who are both identified as carriers of thalassemia, sickle cell disease, cystic fibrosis and Tay‐Sachs disease in healthcare settings, when compared to usual care.